Atlas Trials

Can the Relative Fecal Abundance of BLSE and the Digestive Microbiota be Predictive of the Risk of Infection in a Carrier Patient?

Clinical trial NCT04699981 · UNKNOWN

Trial details

NCT number
NCT04699981
Sponsor
Fondation Hôpital Saint-Joseph
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Enterobacteria Infections
Start date
2022-03-31
Primary completion
2024-03-30
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.